510(k) Report

510(k) · Cleared

Cleared

Advantage Laser System

K113502510(k) TraditionalCleared Apr 5, 2012132-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lutronic Corporation · GEX Powered Laser Surgical Instrument

Cleared on Apr 5, 2012 as substantially equivalent to K053628 (Lumenis, Inc., 2006) after a 132-day review. Its family tree reaches back 1 generation to 2006. 15 later devices descend from it.

Decided
Apr 5, 2012
Review
132 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K053628 (2006). 15 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2014: 1 descendant cleared2018: 1 descendant cleared2019: 1 descendant cleared2022: 3 descendants cleared2026: 3 descendants cleared2020: 2 descendants cleared2023: 1 descendant cleared2025: 2 descendants cleared2024: 1 descendant clearedK053628 · Lightsheer Duet Laser System · Lumenis, Inc. · 200620052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 3 descendants4 generations forward: 5 descendants5 generations forward: 4 descendants6 generations forward: 1 descendant K053628 · Lightsheer Duet Laser System · Lumenis, Inc. · 20060+5
  1. Root · 1 generation backK053628 Lightsheer Duet Laser SystemLumenis, Inc. · 2006
  2. This deviceK113502 Advantage Laser SystemLutronic Corporation · 2012
  3. Descendant · cites it directly · 14 of its ownK141555 AdvantageLutronic Corporation · 2014
  4. Descendant · 2 generations on · 13 of its ownK180719 InMode Diolaze SystemInmode MD, Ltd. · 2018
  5. Descendant · 3 generations on · 8 of its ownK191321 Primelase ExcellenceHigh Technology Products S.L.U · 2019
  6. Descendant · 4 generations on · 3 of its ownK193367 elysion-proHigh Technology Products S.L.U · 2020
  7. Descendant · 3 generations on · 2 of its ownK221571 InMode Multi-systemInMode, Ltd. · 2022

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2014: 12018: 12019: 12020: 22022: 32023: 12024: 12025: 22026: 3
2014high 3 (2022) · low 0 (2015)2026

Most influential descendants

Showing 5 of 15 · See all
  • K141555AdvantageLutronic Corporation · 2014 · cites it directly14descendants
  • K180719InMode Diolaze SystemInmode MD, Ltd. · 2018 · 2 generations on13descendants
  • K191321Primelase ExcellenceHigh Technology Products S.L.U · 2019 · 3 generations on8descendants
  • K193367elysion-proHigh Technology Products S.L.U · 2020 · 4 generations on3descendants
  • K221571InMode Multi-systemInMode, Ltd. · 2022 · 3 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K053628Lightsheer Duet Laser SystemLumenis, Inc.2006—
0 (this device)K113502Advantage Laser SystemLutronic Corporation2012—
+1K141555AdvantageLutronic Corporation2014—
+2K180719InMode Diolaze SystemInmode MD, Ltd.2018—
+3K191321Primelase ExcellenceHigh Technology Products S.L.U2019—
+4K193367elysion-proHigh Technology Products S.L.U2020—
+3K221571InMode Multi-systemInMode, Ltd.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201810
201910
202020
202230
202310
202410
202520
202630
FIG. 1 — Lineage of K113502, 2006–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053628Lightsheer Duet Laser System
Summary page 1
…Product Code: GEX Panel: General & Plastic Surgery 3. Predicate Device Lumenis LightSheer Duet Laser System (K053628) 4. Device Description The ADVANTAGE Laser System is a non-invasive aesthetic laser. The system delivers pulsed…
Lumenis, Inc.2006—

Also cleared against K053628: 8 other devices →

What descends from it? (15)

See all 15

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141555AdvantageLutronic Corporation201414

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K141555 (Lutronic Corporation, 2014) has gone furthest, with 14 descendants of its own.
  • 8 other devices also cite its predicate K053628.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The ADVANTAGE Laser System is indicated for use in surgical, aesthetic, and cosmetic applications in the medical specialties of general and plastic surgery, and dermatology. The ADVANTAGE Laser System is intended for use on all skin types (Fitzpatrick skin types I -VI), including tanned skin. The ADVANTAGE Laser System with H1 Handpiece is indicated for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia and other benign…

Read the full statement (163 words)

The ADVANTAGE Laser System is indicated for use in surgical, aesthetic, and cosmetic applications in the medical specialties of general and plastic surgery, and dermatology. The ADVANTAGE Laser System is intended for use on all skin types (Fitzpatrick skin types I -VI), including tanned skin.

The ADVANTAGE Laser System with H1 Handpiece is indicated for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia and other benign vascular lesions, and the treatment for pseudofolliculitis barbae. The ADVANTAGE Laser System with H1 Handpiece is also indicated for hair removal, permanent hair reduction defined as the long-term stable reduction in the number of hairs re-growing after the last treatment measured at 6, 9 and 12 months, and the treatment of benign pigmented lesions and leg veins.

The ADVANTAGE Laser System with H3 Handpiece is indicated for hair removal and permanent hair reduction defined as the long-term stable reduction in the number of hairs re-growing after the last treatment measured at 6, 9 and 12 months.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113502: Advantage Laser System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113502

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026